Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office	ID
Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers	565
Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers	2507
Hodges, Nick, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers	2276
Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers	2301
Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers	585
Mazurchuk, Richard, Ph.D. richard.mazurchuk@nih.gov 240-276-7126	5E582	Program Officer \| Cancer Biomarkers	587
Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers	597
Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Program Officer \| Cancer Biomarkers	603
Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers	653
Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers	629
Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers	639
Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers	644

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-03	Guillermo Marquez, Ph.D.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02	Guillermo Marquez, Ph.D.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer	5R21CA245651-03	Matthew Young, Ph.D.
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06	Matthew Young, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-07
Patel, Abhijit	Yale University United States	Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood	5U01CA233364-05	Nick Hodges, Ph.D.
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	Matthew Young, Ph.D.
Permuth, Jennifer B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	4R37CA229810-06	Matthew Young, Ph.D.
Phd, Ralph Weissleder, Md,	Massachusetts General Hospital United States	Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)	5R01CA237332-05	Matthew Young, Ph.D.
Pitteri, Sharon	Stanford University United States	Glycosylation and Immune Evasion in Urologic Tumors	5U01CA226051-05	Richard Mazurchuk, Ph.D.
Pollack, Alan	University Of Miami School Of Medicine United States	MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer	5U01CA239141-05	Richard Mazurchuk, Ph.D.
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	1R21CA282380-01A1	Wendy Wang, Ph.D., M.Sc.
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	5R01CA272766-02	Matthew Young, Ph.D.
Radisky, Derek C	Mayo Clinic Jacksonville United States	Involution-based biomarkers of breast cancer risk	3R01CA237602-05S1	Christos Patriotis, Ph.D., M.Sc.
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-11